Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$35.39
-0.1%
$39.15
$25.43
$44.16
$4.76B1.482.38 million shs884,162 shs
Pfizer Inc. stock logo
PFE
Pfizer
$28.64
-1.0%
$27.20
$25.20
$40.37
$162.29B0.6345.22 million shs26.11 million shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
-0.03%+2.03%-6.67%-6.47%+7.50%
Pfizer Inc. stock logo
PFE
Pfizer
-0.99%+2.25%+12.75%+3.71%-22.05%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
4.5341 of 5 stars
4.42.02.50.02.71.71.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9967 of 5 stars
4.25.04.24.82.51.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
2.71
Moderate Buy$46.4331.19% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.40
Hold$35.8625.20% Upside

Current Analyst Ratings

Latest PFE and HOG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$28.00 ➝ $29.00
5/2/2024
Pfizer Inc. stock logo
PFE
Pfizer
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$33.00 ➝ $36.00
4/26/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$50.00 ➝ $45.00
4/23/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight ➝ Overweight$50.00 ➝ $50.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/11/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$42.00 ➝ $49.00
4/3/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$45.00 ➝ $50.00
4/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
3/22/2024
Pfizer Inc. stock logo
PFE
Pfizer
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
3/14/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $55.00
3/5/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$42.00
(Data available from 5/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$5.78B0.82$6.91 per share5.12$24.80 per share1.43
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.77$2.95 per share9.72$16.33 per share1.75

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$706.59M$4.507.867.161.1111.03%19.48%5.21%7/25/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B-$0.06N/A10.381.22-0.56%8.64%3.70%8/6/2024 (Estimated)

Latest PFE and HOG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024Q1 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.56$0.82+$0.26$1.09$13.87 billion$14.88 billion    
4/25/2024Q1 2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$1.48$1.72+$0.24$1.72$1.42 billion$1.48 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
$0.691.95%+14.47%15.33%4 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.685.87%+2.57%N/A 15 Years

Latest PFE and HOG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/17/2024
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
quarterly$0.17251.95%6/5/20246/21/2024
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
1.50
1.54
1.32
Pfizer Inc. stock logo
PFE
Pfizer
0.66
1.05
0.78

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
85.10%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
0.87%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Harley-Davidson, Inc. stock logo
HOG
Harley-Davidson
6,400134.51 million133.34 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable

PFE and HOG Headlines

Recent News About These Companies

Pfizer (NYSE:PFE) Stock Price Down 1.3%
Pfizer Stock: Rebound Has Started (Technical Analysis)
7 Value Stocks to Buy and Hold for a Decade of Dominance
Pfizer (NYSE:PFE) Shares Down 0.1%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Harley-Davidson logo

Harley-Davidson

NYSE:HOG
Harley-Davidson, Inc. manufactures and sells motorcycles in the United States and internationally. The company operates in three segments: Harley-Davidson Motor Company, LiveWire, and Harley-Davidson Financial Services. The Harley-Davidson Motor Company segment designs, manufactures, and sells motorcycles, including cruiser, trike, touring, standard, sportbike, adventure, and dual sport, as well as motorcycle parts, accessories, and apparel, as well as licenses its trademarks and related services. This segment sells its products to retail customers through a network of independent dealers, as well as e-commerce channels. The LiveWire segment sells electric motorcycles, balance bikes for kids, parts and accessories, apparel, and related parts and services. The Harley-Davidson Financial Services segment provides wholesale financing services, such as floorplan and open account financing of motorcycles, and parts and accessories; and retail financing services, such as installment lending for the purchase of new and used Harley-Davidson motorcycles, as well as point-of-sale insurance and voluntary protection products. This segment also licenses third-party financial institutions that issue credit cards bearing the Harley-Davidson brand. Harley-Davidson, Inc. was founded in 1903 and is based in Milwaukee, Wisconsin.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.